Abstract
Hypoglycemia is a common emergency, and is usually due to insulin therapy or oral hypoglycemic treatment in diabetic patients. In some cases, hypoglycemia can be a paraneoplastic sign. We report the case of a 61-year-old woman with a malignant peritoneal mesothelioma, who was admitted to hospital because of diminished consciousness. The final diagnosis was paraneoplastic hypoglycemia with a positive response to glucagon. The patient was finally discharged with glucagon perfusion.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Coma / etiology
-
Fatal Outcome
-
Female
-
Glucagon / administration & dosage
-
Glucagon / therapeutic use*
-
Humans
-
Hypoglycemia / drug therapy*
-
Hypoglycemia / etiology
-
Infusions, Intravenous
-
Insulin-Like Growth Factor II / metabolism
-
Mesothelioma / complications
-
Mesothelioma / drug therapy
-
Mesothelioma / metabolism
-
Middle Aged
-
Models, Biological
-
Palliative Care
-
Paraneoplastic Syndromes / drug therapy*
-
Paraneoplastic Syndromes / etiology
-
Perfusion
-
Peritoneal Neoplasms / complications
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / metabolism
-
Protein Precursors / metabolism
-
Recurrence
Substances
-
Antineoplastic Agents
-
Protein Precursors
-
proinsulin-like growth factor II
-
Insulin-Like Growth Factor II
-
Glucagon